A pH-sensitive delivery system based on N-succinyl chitosan-ZnO nanoparticles for improving antibacterial and anticancer activities of curcumin.
Anti-Bacterial Agents
/ chemistry
Antineoplastic Agents
/ chemistry
Apoptosis
/ drug effects
Cell Line, Tumor
Cell Survival
/ drug effects
Chemistry Techniques, Synthetic
Chitosan
/ chemistry
Curcumin
/ chemistry
Drug Carriers
/ chemical synthesis
Drug Delivery Systems
Drug Liberation
Humans
Hydrogen-Ion Concentration
Kinetics
Microbial Sensitivity Tests
Nanoparticles
/ chemistry
Spectrum Analysis
Zinc Oxide
/ chemistry
Chitosan
Stimuli-responsive drug delivery systems
Zinc oxide nanostructures
Journal
International journal of biological macromolecules
ISSN: 1879-0003
Titre abrégé: Int J Biol Macromol
Pays: Netherlands
ID NLM: 7909578
Informations de publication
Date de publication:
15 May 2020
15 May 2020
Historique:
received:
28
11
2019
revised:
12
02
2020
accepted:
13
02
2020
pubmed:
19
2
2020
medline:
4
2
2021
entrez:
19
2
2020
Statut:
ppublish
Résumé
Inherent selective cytotoxicity, antibacterial activity and unique physicochemical properties of ZnO nanostructures and chitosan (CS) make them promising candidates for drug delivery. In this study, ZnO nanoparticles functionalized by N-succinyl chitosan as a pH-sensitive delivery system were synthesized to enhance the therapeutic potential of curcumin (CUR). CS coated-ZnO nanoparticles were synthesized by a co-precipitation method in the presence of CS. Chemical modification of CS-ZnO particles was performed by succinic anhydride for introducing -COOH functional groups which were then activated using 1,1'‑carbonyldiimidazole for CUR conjugation. The spherical-like CUR-conjugated system (CUR-CS-ZnO) with the average particle size of 40 nm presented significantly enhanced water dispersibility versus free CUR. The experimental study of CUR release from the system showed a pH-sensitive release profile, which enabled drug delivery to tumors and infection sites. MTT and Annexin-V FITC/PI assays revealed the superior anticancer activity of CUR-CS-ZnO compared to free CUR against breast cancer cells (MDA-MB-231) by inducing the apoptotic response with no cytotoxic effects on HEK293 normal cells. Moreover, CUR conjugation to the system notably dropped the MIC (25 to 50-fold) and MBC values (10 to 40-fold) against S. aureus and E. coli. The features qualify the formulation for anticancer and antimicrobial applications in the future.
Identifiants
pubmed: 32068061
pii: S0141-8130(19)39790-9
doi: 10.1016/j.ijbiomac.2020.02.141
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Antineoplastic Agents
0
Drug Carriers
0
N-succinyl-chitosan
0
Chitosan
9012-76-4
Curcumin
IT942ZTH98
Zinc Oxide
SOI2LOH54Z
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
428-440Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.